Maximus, Inc. (NYSE:MMS) Shares Sold by Central Pacific Bank Trust Division

Central Pacific Bank Trust Division lowered its stake in Maximus, Inc. (NYSE:MMS) by 28.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,920 shares of the health services provider’s stock after selling 770 shares during the period. Central Pacific Bank Trust Division’s holdings in Maximus were worth $179,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of MMS. UBS Group AG increased its holdings in shares of Maximus by 60.7% in the 4th quarter. UBS Group AG now owns 72,724 shares of the health services provider’s stock valued at $6,099,000 after acquiring an additional 27,466 shares during the last quarter. TD Asset Management Inc increased its holdings in shares of Maximus by 8.1% in the 4th quarter. TD Asset Management Inc now owns 29,300 shares of the health services provider’s stock valued at $2,457,000 after acquiring an additional 2,200 shares during the last quarter. Dean Capital Management increased its holdings in shares of Maximus by 61.6% in the 4th quarter. Dean Capital Management now owns 16,233 shares of the health services provider’s stock valued at $1,361,000 after acquiring an additional 6,186 shares during the last quarter. Cim Investment Management Inc. purchased a new position in shares of Maximus in the 4th quarter valued at about $202,000. Finally, Virtu Financial LLC increased its holdings in shares of Maximus by 8.3% in the 4th quarter. Virtu Financial LLC now owns 3,102 shares of the health services provider’s stock valued at $260,000 after acquiring an additional 237 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 1,363 shares of the stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $92.56, for a total transaction of $126,159.28. Following the completion of the sale, the insider now directly owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.40% of the stock is owned by insiders.

Maximus Trading Up 0.1 %

NYSE:MMS opened at $91.25 on Friday. The stock’s 50 day moving average price is $89.98 and its 200 day moving average price is $86.67. The company has a market capitalization of $5.55 billion, a PE ratio of 23.95 and a beta of 0.76. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.61. Maximus, Inc. has a 52-week low of $72.81 and a 52-week high of $93.97.

Maximus (NYSE:MMS) last released its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.47 by $0.27. The firm had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 20.91% and a net margin of 5.59%. The firm’s quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.78 EPS. On average, research analysts anticipate that Maximus, Inc. will post 6.12 EPS for the current year.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.